Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7547 | 1275 | 45.5 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TENASCIN C | Author keyword | 213 | 57% | 20% | 250 |
2 | TENASCIN | Author keyword | 148 | 46% | 19% | 244 |
3 | TENASCIN X | Author keyword | 94 | 89% | 3% | 42 |
4 | CYTOTACTIN | Author keyword | 49 | 94% | 1% | 17 |
5 | PATHOL MATRIX BIOL | Address | 35 | 59% | 3% | 40 |
6 | TENASCIN R | Author keyword | 22 | 57% | 2% | 26 |
7 | CELL MORPHOL MOL NEUROBIOL | Address | 14 | 41% | 2% | 27 |
8 | HEXABRACHION | Author keyword | 12 | 86% | 0% | 6 |
9 | RESTRICTIN | Author keyword | 9 | 83% | 0% | 5 |
10 | ALTERNATIVELY SPLICED REGION | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TENASCIN C | 213 | 57% | 20% | 250 | Search TENASCIN+C | Search TENASCIN+C |
2 | TENASCIN | 148 | 46% | 19% | 244 | Search TENASCIN | Search TENASCIN |
3 | TENASCIN X | 94 | 89% | 3% | 42 | Search TENASCIN+X | Search TENASCIN+X |
4 | CYTOTACTIN | 49 | 94% | 1% | 17 | Search CYTOTACTIN | Search CYTOTACTIN |
5 | TENASCIN R | 22 | 57% | 2% | 26 | Search TENASCIN+R | Search TENASCIN+R |
6 | HEXABRACHION | 12 | 86% | 0% | 6 | Search HEXABRACHION | Search HEXABRACHION |
7 | RESTRICTIN | 9 | 83% | 0% | 5 | Search RESTRICTIN | Search RESTRICTIN |
8 | ALTERNATIVELY SPLICED REGION | 6 | 100% | 0% | 4 | Search ALTERNATIVELY+SPLICED+REGION | Search ALTERNATIVELY+SPLICED+REGION |
9 | FN III REPEAT | 6 | 100% | 0% | 4 | Search FN+III+REPEAT | Search FN+III+REPEAT |
10 | J1 160 180 | 3 | 100% | 0% | 3 | Search J1+160+180 | Search J1+160+180 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOTACTIN | 184 | 79% | 9% | 116 |
2 | EXTRACELLULAR MATRIX PROTEIN | 142 | 49% | 16% | 208 |
3 | CHICK MYOTENDINOUS ANTIGEN | 79 | 74% | 5% | 58 |
4 | HUMAN HEXABRACHION TENASCIN | 52 | 100% | 1% | 18 |
5 | HEXABRACHION | 50 | 88% | 2% | 23 |
6 | MATRIX PROTEIN TENASCIN | 44 | 100% | 1% | 16 |
7 | HEXABRACHION TENASCIN | 41 | 90% | 1% | 18 |
8 | HEXABRACHION PROTEINS | 35 | 89% | 1% | 16 |
9 | J1 160 180 | 21 | 90% | 1% | 9 |
10 | INVASION BORDER | 19 | 76% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tenascins in fibrotic disorders-from bench to bedside | 2015 | 1 | 70 | 61% |
The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling | 2000 | 375 | 268 | 57% |
Tenascins: regulation and putative functions during pathological stress | 2003 | 264 | 171 | 65% |
Advances in tenascin-C biology | 2011 | 62 | 182 | 58% |
Tenascin-C induced signaling in cancer | 2006 | 135 | 149 | 51% |
Meet the tenascins: Multifunctional and mysterious | 2005 | 80 | 48 | 88% |
Tenascins in stem cell niches | 2014 | 7 | 132 | 64% |
Tenascin-C in development and disease: gene regulation and cell function | 2000 | 187 | 152 | 59% |
The regulation of tenascin expression by tissue microenvironments | 2009 | 48 | 82 | 76% |
Expression of tenascin-C and its isoforms in the breast | 2010 | 18 | 116 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOL MATRIX BIOL | 35 | 59% | 3.1% | 40 |
2 | CELL MORPHOL MOL NEUROBIOL | 14 | 41% | 2.1% | 27 |
3 | BIOSIGNALING RADIOISOTOPE EXPT | 4 | 44% | 0.5% | 7 |
4 | NEPHROL CARDIOL | 4 | 30% | 0.8% | 10 |
5 | FRIEDRICH MIE ER BIOMED | 3 | 15% | 1.3% | 17 |
6 | NEURO TUMOR CELL BIOL GRP | 3 | 42% | 0.4% | 5 |
7 | BIOL CHIM PROTIFR BIOSCI LYON GERLAND 128 | 2 | 67% | 0.2% | 2 |
8 | MED CELL BIOL HUMAN ANAT | 2 | 67% | 0.2% | 2 |
9 | UMR S682 | 1 | 38% | 0.2% | 3 |
10 | FR3302 | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000141548 | PERINEURONAL NET//PERINEURONAL NETS//NEUROCAN |
2 | 0.0000079310 | EPENDYMIN//HNK 1 CARBOHYDRATE//GLUCURONYLTRANSFERASE |
3 | 0.0000074216 | ODZ//TEN M//TENEURIN |
4 | 0.0000073666 | EXTRA DOMAIN A CONTAINING FIBRONECTIN//FIBRONECTIN DOMAINS//RECOMBINANT FIBRONECTIN FRAGMENT |
5 | 0.0000067809 | EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI |
6 | 0.0000055729 | L1 CAM//X LINKED HYDROCEPHALUS//MASA SYNDROME |
7 | 0.0000053807 | IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG |
8 | 0.0000052976 | LTBP//ALPHA V BETA 6//INTEGRIN ALPHAVBETA6 |
9 | 0.0000052069 | ENT DIS HEAD NECK SURG//CYTOSKELETAL PHENOTYPE//CARCINOMA CELL INVASION |
10 | 0.0000048098 | NEPHRONECTIN//VLA 1//ALPHA 8 INTEGRIN |